Our researchers at the Kolling Institute are encouraging those with osteoarthritis to rely on treatments with a proven track record and avoid quick fixes without the data to show they work. The comments follow a steady rise in osteoarthritis cases nationally, with around three million Australians now living with the condition, and many forced to retire early. The rise in cases has coinci.....
Read more

A new study by researchers at the Kolling Institute estimates more than 800 million people will be living with low back pain by 2050, a 36 percent increase from 2020. The prediction follows an analysis of 30 years of global health data from over 200 countries. Modelling shows the number of back pain cases globally will rise to 843 million people by 2050, while in Australia, it’s expected.....
Read more

In a sign of the international impact of our research at the Kolling Institute, a prestigious award has been presented to Professor Chris Little during the World Congress on Osteoarthritis in Denver, Colorado. More than 700 researchers and clinicians attended the event where Professor Little was presented with the 2023 Basic Science Research Award by the Osteoarthritis Research Society I.....
Read more

We are pleased to announce the successful recipients of our annual Kolling Institute awards program. Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling. The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well a.....
Read more

With an increasing number of people suffering anterior cruciate ligament (ACL) injuries, researchers at the Kolling Institute say a broader range of tendon grafts could be successfully adopted by surgeons undertaking knee reconstructions. The research, which is the second-largest human tendon study ever published, is prompting calls for tissue banks to review current age restrictions and.....
Read more

Arthritis is the third most prevalent long-term health condition in Australia affecting more than 12 per cent of Australians. There is no cure for arthritis, with treatment options largely focused on alleviating pain, including pain relief medication, arthroscopy or joint replacement. Australia is at the forefront of clinical research and trials, which is helping the community better man.....
Read more

We would like to congratulate Professor Chris Little who has received a highly coveted award for his outstanding commitment to orthopaedic research. Professor Little has been elected a Fellow of International Orthopaedic Research at a key international conference in Edinburgh Scotland. The award is only presented every three years, with around 20 people across the globe receiving the acc.....
Read more

A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute. Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities. It is the largest of its kind in Australia and one of just two SimVitro ro.....
Read more

Kolling Institute researchers have helped map out exciting future developments for the rehabilitation of hip and knee replacement patients. A team of researchers from Sydney Musculoskeletal Health – a partnership between the University of Sydney, Sydney Local Health District and Northern Sydney Local Health District - recently attended the International Society for Technology in Arthropl.....
Read more

Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is re.....
Read more